Printer Friendly

Putting a stop to surgical bleeding.

With the rise of more complex surgeries, new hemostatic agents are being developed to aid surgeons in controlling surgical bleeding. It's important, therefore, that surgeons select the optimal hemostat for a given clinical circumstance. Ethicon's EVARREST, a novel bioabsorbable hemostat, represents the convergence of biologics and a medical device (flexible patch) that, when combined, form a distinct delivery system that raises the standard of care for surgeons and their patients. Each component of EVARREST--a Oxidized Regenerated Cellulose (ORC) underlying layer, nonwoven polyglactin 910 fibers needle-punched into the underlying ORC layer to provide increased surface area and mechanical strength and a surface layer of lyophilized human fibrinogen and human thrombin--plays an active role in the hemostasis process. The biologics (human thrombin and fibrinogen) react and initiate a fibrin clot, which then integrates into the patch, providing mechanical support and adherence to the wound site.

* Ethicon,

COPYRIGHT 2015 Advantage Business Media
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:R&D100: Analytical/Test
Publication:R & D
Date:Nov 1, 2015
Previous Article:Reprogramming RNA.
Next Article:Streamlining water quality.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters